Royal BAM


Same old story: cost overruns ruin the already tough business

24/02/20 -"Very weak results and basically a year without a dividend. Bottom line: this company can be profitable, but it needs to get better at tendering "

Pages
52
Language
English
Published on
24/02/20
You may also be interested by these reports :
14/05/24
Fraport’s Q1 results exceeded the market’s expectations, supported by one-off compensation at Greek airports for the adverse impacts of the COVID-19 ...

09/05/24
Since our last Teaser on the stock, ACS’s (Buy; Spain) share price has surged by 29%, reflecting the market’s favourable response to the ...

03/05/24
We have incorporated the lower-than-estimated FY23 results into our model, as the costs reported by the company exceeded our estimates. For the ...

02/05/24
BAM reported negative Q1 results, with certain projects experiencing cost overruns and delays in core markets. Despite encountering operational ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO